Forbes |
When Clinical Trials Are Marketing Ploys, Not Science
Forbes Ethicists have long warned that conducting trials for the sole purpose of influencing physician prescribing behavior undermines the entire research process and increases distrust towards scientists. Kimmelman and Federico also co-authored a paper in ... |
Thursday 29 November 2018
When Clinical Trials Are Marketing Ploys, Not Science - Forbes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment